GENAISSANCE PHARMACEUTICALS INC·4

Jan 21, 1:41 PM ET

Kalnik Matthew Walter 4

4 · GENAISSANCE PHARMACEUTICALS INC · Filed Jan 21, 2005

Insider Transaction Report

Form 4
Period: 2005-01-07
Kalnik Matthew Walter
Sr. V.P., Business Development
Transactions
  • Award

    Common Stock

    2005-01-07$0.00/sh+25,000$2525,500 total
  • Award

    Stock Option (Right to Buy)

    2005-01-07$2.20/sh+75,000$165,00075,000 total
    Exercise: $2.20From: 2009-01-07Exp: 2015-01-06Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]This option vests in quarterly increments of 6.25% beginning on 4/7/05.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -